elzasonan 化学特性,用途語,生産方法
使用
Elzasonan is a selective 5-hydroxytryptamine 1B receptor antagonist that was developed by Pfizer (and then later discontinued in 2008) to treat patients with major depressive disorder and obsessive compulsive disorder.
elzasonan 上流と下流の製品情報
原材料
準備製品